-

Pulse8’s Qualit8 Solution receives NCQA Measure Certification Programfor HEDIS® MY 2020 Season

Certification to deliver value and administrative efficiency to Pulse8 customers

ANNAPOLIS, Md.--(BUSINESS WIRE)--Pulse8, a Veradigm® business, is thrilled to announce MY 2020 Measure Certification from the National Committee for Quality Assurance (NCQA) for Qualit8. This demonstrates an extension of its product portfolio by combining its proven Quality Improvement Analytics (Qualit8™) with an NCQA-Certified HEDIS® Measurement & Reporting Software and HEDIS® Submission system (Qualit8™ Platinum) that will deliver value and administrative efficiency to its health plan customers.

Pulse8’s NCQA-Certified HEDIS MY 2020 Measures will provide the following value within the Qualit8 solution:

  • Process all HEDIS MY 2020 measures
  • Support MRR Hybrid Measure Sample Frames
  • Support Survey Sample Frames
  • And much more…

“Pulse8 is committed to our priority of bringing industry-leading, transparent analytics to your plan and is excited to announce our new NCQA Certification of Qualit8,” says Co-President and Chief Product Officer, Courtney Yeakel. “Our focus continues to be on eliminating unnecessary interventions that deliver little value and waste precious time and resources, so you can focus your energy on what matters.”

You can learn more about Qualit8 Certification and Pulse8’s full suite of products at https://pulse8.com/.

NCQA is a private, non-profit organization dedicated to improving health care quality. NCQA Measure Certification Program™ is a trademark of the National Committee for Quality Assurance (NCQA). HEDIS® is a registered trademark of the of the National Committee for Quality Assurance (NCQA).

About Pulse8

Pulse8 is a Healthcare Analytics and Technology business delivering visibility into the efficacy of your Risk Adjustment, Quality, and Pharmacy Benefit Management programs. We enable health plans and providers to eliminate waste and achieve the greatest financial impact in the Medicare Advantage, Medicaid, and ACA Commercial markets as well as with Value-Based Payment models for Medicare. Our advanced analytic methodologies and flexible business intelligence tools offer real-time visibility into member behavior and provider performance. For more information or to schedule a demo, please Info@Pulse8.com.

About Veradigm®

Veradigm® is a business unit of Allscripts, dedicated to simplifying the complicated healthcare system with next-generation healthcare solutions. An integrated clinical technology team combining data-driven clinical insights with actionable tools to help healthcare stakeholders improve the quality, efficiency, and the value of healthcare, Veradigm is helping transform healthcare for biopharma, health plans, healthcare providers, health technology partners, and most importantly, the patients they serve. To learn more, visit www.veradigm.com.

About Allscripts

Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers to make better decisions and deliver better care for healthier populations. To learn more, visit www.allscripts.com, Twitter, YouTube and It Takes A Community: The Allscripts Blog.

© 2021 Allscripts Healthcare, LLC and/or its affiliates. All Rights Reserved.

Contacts

For more information contact:

John Cover
602-315-5206
John.Cover@Pulse8.com

Investors:
Stephen Shulstein
312-386-6735
Stephen.Shulstein@allscripts.com

Media:
Concetta Rasiarmos
312-447-2466
concetta.rasiarmos@allscripts.com

Allscripts Logo
Allscripts Logo

Allscripts

NASDAQ:MDRX

Release Versions
Hashtags

Contacts

For more information contact:

John Cover
602-315-5206
John.Cover@Pulse8.com

Investors:
Stephen Shulstein
312-386-6735
Stephen.Shulstein@allscripts.com

Media:
Concetta Rasiarmos
312-447-2466
concetta.rasiarmos@allscripts.com

More News From Allscripts

Veradigm Extends Stockholder Rights Plan

CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, today announced that its Board of Directors (the “Board”) has approved an amendment to extend the Company’s existing Stockholder Rights Plan to December 31, 2026 (the “Rights Plan”). The Board's decision to extend the Rights Plan is based on its determination that many of the underlying risks and conditions that existed upon the initial adoption of the Right...

Veradigm Launches New AI Application for Powerful Revenue Cycle Insights for Independent Practices

CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, today announced the launch of a new AI-enabled application for Veradigm Revenue Cycle Services (RCS) clients, designed to deliver faster, deeper revenue cycle insights and strengthen the value of ongoing performance reviews for independent practices. Independent practices continue to face rising administrative complexity and financial pressure, driven by den...

Veradigm and Meperia Launch Industry-First 8-Way Match EDI Platform to Strengthen Healthcare Supply Chain Integrity

CHICAGO & VERO BEACH, Fla.--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data, technology, and enterprise resource planning (ERP) solutions, and Meperia (now part of Genesis Automation Healthcare), a healthcare supply chain technology company specializing in AI-powered content and spend management solutions, announced today a strategic collaboration to launch a next-generation Electronic Data Interchange (EDI) solution, purpose-built for healthcare. This new EDI...
Back to Newsroom